Oculis Holding AG OCS
NASDAQ OCS
$7.86 +0.37 (+4.88%)
As of: Oct 21, 2026 · 3:56 PM EDT

Oculis Holding AG (OCS) Debt Ratio (2021 - 2026)

Updated

Oculis Holding AG's (OCS) Debt Ratio stood at 3.30 in Q4 2022, up 69.0% from 1.96 a year earlier.

Analysis

Oculis Holding AG (OCS) Debt Ratio (2021 - 2026) Analysis & Trends

  • Across earlier years, Debt Ratio came in at 1.96 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn 0.24
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn 0.52
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn 0.42
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn 0.08
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn 0.28
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn 0.53
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn 0.31
10 Oculis Holding AG 408.54 Mn -602.93 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Jun 30, 2025 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Dec 31, 2022 3.30
Dec 31, 2021 1.96
API Access

Oculis Holding AG Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=OCS&period=max&api_key=YOUR_API_KEY